Table 1 Demographic and clinical data.
From: Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation
Baseline characteristics | HD Patients (n = 10) | RTX Patients (n = 19) |
|---|---|---|
   Age, yr | 57 ± 4 | 58 ± 3 |
   Male sex, n | 7 | 12 |
   Hx hypertension, n | 7 | 11 |
   Hx dyslipidemia, n | 6 | 10 |
   Hx smoking, n | 6 | 5 |
   Hx CVD, n | 5 | 10 |
   Hx Diabetes, n | 2 | 2 |
   Serum creatinine, mg/dl | 7.6 ± 0.7 | 1.8 ± 0.2 |
   Blood urea nitrogen, mg/dl | 112 ± 5 | 72 ± 10 |
Medication, n (%) | Â | Â |
   Alpha-blockers | 3 | 1 |
   Beta-blockers | 6 | 15 |
   ACE-inhibitors/At-II-antagonists | 6 | 11 |
   Calcium antagonists | 5 | 2 |
   Central sympatholytic agents | 3 | 6 |
   Diuretics | 5 | 10 |
   Cyclosporine | 0 | 10 |
   Tacrolimus | 0 | 9 |